FOSTER CITY, CA–(Marketwire – Dec 4, 2012) – SciClone Pharmaceuticals, Inc. ( NASDAQ : SCLN ) today arise that its anew created anti-counterfeiting Pharma-Comb Void characterization for ZADAXIN has won the celebrated “Innovator Award” in the anniversary antagonism sponsored by the Tag and Characterization Manufacturers Institute (TLMI). The ZADAXIN label, which was created for SciClone by Schreiner MediPharm, a Germany-based developer and architect of biologic specialty labels, is based on an avant-garde multi-part abstraction to ensure artefact assurance and aegis and to annul the actionable convenance of refilling ahead acclimated anesthetic vials.
“Drug counterfeiting is a austere claiming adverse the biologic industry, accessible bloom and authoritative authorities worldwide, advancing accommodating safety, compromising the accumulation and capability of medical interventions and harming the bartering activity of important biologic therapies,” said Friedhelm Blobel, Ph.D., SciClone’s Chief Executive Officer. “SciClone is committed to ensuring accommodating assurance and aegis for all of our marketed products. We intend to abide accomplishing of an advancing anti-counterfeiting action for ZADAXIN, and to assignment in affiliation with agencies and bloom authorities to action the abomination of trafficking in actionable medicines.”
The ZADAXIN Pharma-Comb Void characterization is advised to be functionally destroyed during its antecedent use. When the label’s breach band — which additionally runs about the cease cap — is removed, the inscriptions “Opened” and “Used” arise in the film’s two indicator fields. This architecture is advised to accomplish the undetected reclaim of a bottle alembic with an aboriginal characterization about impossible. SciClone believes that the Pharma-Comb Void characterization overcomes the limitations of accepted vial which, alike back able with apparent aegis features, such as holograms or color-shifting inks, can be abounding a added time and awash as originals after detection. The new ZADAXIN characterization is advised to annul this practice, and additionally offers a admired added account for healthcare professionals: back the characterization is opened, a advertisement allotment is arise that serves to mark the syringe accordingly.
SciClone Pharmaceuticals is a US-based, China-focused specialty biologic aggregation with a artefact portfolio of therapies for oncology, communicable diseases and cardiovascular, urological, respiratory, and axial afraid arrangement disorders. SciClone’s ZADAXIN® (thymalfasin) is accustomed in over 30 countries and may be acclimated for the analysis of hepatitis B (HBV), hepatitis C (HCV) and assertive cancers, and as a vaccine adjuvant, according to the bounded authoritative approvals. Besides ZADAXIN, SciClone markets about 14 mostly partnered articles in China, including Depakine®, the best broadly assigned broad-spectrum anti-convulsant in China; Tritace®, an ACE inhibitor for the analysis of hypertension; Stilnox®, a fast-acting anesthetic for the concise analysis of indisposition (marketed as Ambien® in the US); and Aggrastat®, a recently-launched interventional cardiology product. SciClone is additionally advancing the allotment of several added ameliorative articles in China. SciClone is headquartered in Foster City, California. For added information, amuse appointment www.sciclone.com.
Ambien, Depakine, Stilnox and Tritace are registered trademarks of Sanofi and/or its affiliates.
Aggrastat is a registered brand of Medicure International Inc. in the United States, and Iroko Cardio LLC in abundant added countries.
DC Bead is a registered brand of Biocompatibles UK Limited.
SciClone, SciClone Pharmaceuticals, the SciClone Pharmaceuticals design, the SciClone logo and ZADAXIN are registered trademarks of SciClone Pharmaceuticals, Inc. in the United States and abundant added countries.
About Schreiner MediPharm
Based in the Munich breadth of Germany, Schreiner MediPharm is a all-around baton in the development and accomplish of avant-garde specialty labels with value-added allowances that accept set the accepted in the healthcare and biologic industries. Schreiner MediPharm’s ability is based on over 60 years of experience. The family-owned aggregation provides specialty labels and characterization press casework to the better names in the healthcare bazaar in over 20 countries about the world, including Japan. Schreiner MediPharm’s U.S. facility, a business assemblage of Schreiner Group LP, is amid in Blauvelt, NY. For added information, amuse appointment www.schreiner-medipharm.com.
Ten Unexpected Ways Puma Anti Counterfeit Label Can Make Your Life Better | Puma Anti Counterfeit Label – puma anti counterfeit label
| Delightful in order to my personal website, on this occasion I will explain to you regarding puma anti counterfeit label